Why is Torrent Pharma falling/rising?

As of 28-Aug, Torrent Pharmaceuticals Ltd. is experiencing a decline in its stock price, currently at 3,571.05, reflecting a decrease of 30.85 points or 0.86%. The stock has been losing value for the last three days, with a total drop of 3.26% during this period. Despite this recent downturn, the company has shown strong performance over the longer term, with a year-to-date increase of 6.42% and a remarkable 130.84% rise over the past three years. The stock's performance today is in line with its sector, and it remains above its 50-day, 100-day, and 200-day moving averages, although it is below the 5-day and 20-day moving averages. Additionally, there has been a notable increase in investor participation, with delivery volume rising by 107.98% compared to the 5-day average, indicating a healthy level of liquidity.
In the broader market context, Torrent Pharmaceuticals' recent short-term performance has outpaced the benchmark Sensex, which has fallen by 2.34% over the past week. The company's strong fundamentals, including a high return on capital employed (ROCE) of 22.33% and a low debt-to-EBITDA ratio of 1.26 times, suggest that it has a solid ability to manage its finances effectively. Furthermore, the company has consistently delivered positive results over the last eight quarters, contributing to its long-term outperformance against the BSE500. Despite the recent price decline, the high institutional holdings at 24.75% reflect confidence from more sophisticated investors, which may provide a stabilizing effect on the stock's future performance.